March 22, 2025 - 17:44

MARIETTA — Memorial Health System’s Department of Cardiology recently celebrated a significant achievement in advanced cardiac care by completing its 100th transcatheter aortic valve replacement (TAVR) procedure. This milestone was reached under the expertise of Interventional Cardiologist Jason Schott, DO, and Cardiothoracic Surgeon Geoffrey R. Cousins, MD, FACS.
As the only health system in the region providing TAVR, Memorial Health System has established itself as a leader in innovative heart treatments. The TAVR procedure offers a less invasive option for patients suffering from aortic valve stenosis, allowing for quicker recovery times compared to traditional open-heart surgery.
The success of the program reflects the dedicated efforts of the entire cardiology team, who are committed to improving patient outcomes and enhancing the quality of care. With this achievement, Memorial Health System continues to pave the way for advanced cardiac solutions, ensuring that patients receive the best possible treatment close to home.
February 2, 2026 - 18:41
This global health leader praises Trump's aid plan -- and gears up to beat malariaBill Steiger, a seasoned figure with senior roles in both the George H.W. Bush and Trump administrations, is now leading the charge against one of the world`s oldest diseases. As the new head of...
February 2, 2026 - 11:57
Letters: Claims using data about environment and health should be viewed skepticallyA recent online resource presenting parish-level health statistics has sparked debate by suggesting that public concerns over Louisiana`s industrial corridor may be exaggerated. The site utilizes...
February 1, 2026 - 21:40
Lou Holtz's son shares health update after college football coaching legend enters hospice careSkip Holtz, son of iconic college football coach Lou Holtz, provided a brief statement regarding his father`s condition on Sunday. The update comes as the elder Holtz, 87, receives hospice...
February 1, 2026 - 14:47
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland ChinaSHANGHAI, February 01, 2026--A new strategic collaboration has been formed between Tenacia Biopharmaceuticals and Golden Age Health (GAH) to commercialize the therapy ZTALMY® in mainland China....